NEWSROUND
Selected Reports by Janet Fricker Download full article
imatinib
NEWSROUND
Selected reports edited by Janet Fricker Download full article
The treatment of gastrointestinal stromal tumours (GIST)
Better understanding of the different mutations that drive GIST is leading to new paradigms of tailored treatment that break many norms of chemotherapy, especially in management of progression. Download full article
GIST adjuvant therapy – some answers and more questions
Imatinib is known to be effective in the first-line treatment of metastatic gastrointestinal stromal tumours. A randomised, placebo-controlled trial has now shown that imatinib is safe and improves recurrence-free survival when used as adjuvant therapy [more]